578 related articles for article (PubMed ID: 21955193)
1. Neuro-oncology: a selected review of ASCO 2011 abstracts.
Chamberlain MC
Expert Rev Neurother; 2011 Oct; 11(10):1371-7. PubMed ID: 21955193
[TBL] [Abstract][Full Text] [Related]
2. Neuro-oncology: a selected review of ASCO 2012 abstracts.
Chamberlain MC
CNS Oncol; 2012 Nov; 1(2):127-30. PubMed ID: 25057862
[TBL] [Abstract][Full Text] [Related]
3. Neuro-oncology: a selected review of ASCO 2016 abstracts.
Chamberlain MC
CNS Oncol; 2016 Oct; 5(4):193-8. PubMed ID: 27616612
[TBL] [Abstract][Full Text] [Related]
4. A selected review of abstracts from the 11th Congress of the European Association of Neuro-Oncology (EANO).
Chamberlain MC
CNS Oncol; 2015; 4(1):5-9. PubMed ID: 25586421
[TBL] [Abstract][Full Text] [Related]
5. A selected review of abstracts from the 19th annual meeting of the Society for Neuro-Oncology.
Chamberlain MC
CNS Oncol; 2015; 4(3):125-9. PubMed ID: 25906288
[TBL] [Abstract][Full Text] [Related]
6. A selected review of abstracts from the 17th Annual Scientific Meeting of the Society for Neuro-Oncology.
Chamberlain MC
CNS Oncol; 2013 Mar; 2(2):117-20. PubMed ID: 25057974
[TBL] [Abstract][Full Text] [Related]
7. Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
Morgensztern D; Pennell NA; Subramanian J; Govindan R
Clin Lung Cancer; 2011 Mar; 12(2):94-9. PubMed ID: 21550555
[TBL] [Abstract][Full Text] [Related]
8. [American Society of Clinical Oncology (ASCO) 2012 essential data: the editorial board of the Bulletin du Cancer point of view].
Magné N; Bay JO; Blay JY; Gonçalves A; Massard C; Thariat J; Wislez M; André T; Vignot S
Bull Cancer; 2012 Dec; 99(12):1209-17. PubMed ID: 23306389
[TBL] [Abstract][Full Text] [Related]
9. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
10. A selected review of abstracts from the 20th Annual Meeting of the Society for Neuro-Oncology (SNO).
Chamberlain MC
CNS Oncol; 2016 Jul; 5(3):115-9. PubMed ID: 27230972
[TBL] [Abstract][Full Text] [Related]
11. Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Gralow J; Ozols RF; Bajorin DF; Cheson BD; Sandler HM; Winer EP; Bonner J; Demetri GD; Curran W; Ganz PA; Kramer BS; Kris MG; Markman M; Mayer RJ; Raghavan D; Ramsey S; Reaman GH; Sawaya R; Schuchter LM; Sweetenham JW; Vahdat LT; Davidson NE; Schilsky RL; Lichter AS;
J Clin Oncol; 2008 Jan; 26(2):313-25. PubMed ID: 18086794
[TBL] [Abstract][Full Text] [Related]
12. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
Guillem JG; Wood WC; Moley JF; Berchuck A; Karlan BY; Mutch DG; Gagel RF; Weitzel J; Morrow M; Weber BL; Giardiello F; Rodriguez-Bigas MA; Church J; Gruber S; Offit K; ;
J Clin Oncol; 2006 Oct; 24(28):4642-60. PubMed ID: 17008706
[TBL] [Abstract][Full Text] [Related]
13. Quality of abstracts describing randomized trials in the proceedings of American Society of Clinical Oncology meetings: guidelines for improved reporting.
Krzyzanowska MK; Pintilie M; Brezden-Masley C; Dent R; Tannock IF
J Clin Oncol; 2004 May; 22(10):1993-9. PubMed ID: 15143092
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Hsu C; Saif MW
JOP; 2011 Jul; 12(4):330-3. PubMed ID: 21737889
[TBL] [Abstract][Full Text] [Related]
15. Consistency of phase III clinical trial abstracts presented at an annual meeting of the American Society of Clinical Oncology compared with their subsequent full-text publications.
Tam VC; Hotte SJ
J Clin Oncol; 2008 May; 26(13):2205-11. PubMed ID: 18445846
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics and other molecular targets in the management of pancreatic adenocarcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Merika E; Syrigos KN; Saif MW
JOP; 2010 Jul; 11(4):328-30. PubMed ID: 20601804
[TBL] [Abstract][Full Text] [Related]
17. Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Chang BW; Siccion E; Saif MW
JOP; 2010 Jul; 11(4):313-6. PubMed ID: 20601800
[TBL] [Abstract][Full Text] [Related]
18. Second line therapy for advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Brus C; Saif MW
JOP; 2010 Jul; 11(4):321-3. PubMed ID: 20601802
[TBL] [Abstract][Full Text] [Related]
19. Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Herbst RS; Bajorin DF; Bleiberg H; Blum D; Hao D; Johnson BE; Ozols RF; Demetri GD; Ganz PA; Kris MG; Levin B; Markman M; Raghavan D; Reaman GH; Sawaya R; Schuchter LM; Sweetenham JW; Vahdat LT; Vokes EE; Winn RJ; Mayer RJ;
J Clin Oncol; 2006 Jan; 24(1):190-205. PubMed ID: 16326753
[TBL] [Abstract][Full Text] [Related]
20. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
